These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

945 related items for PubMed ID: 20837338

  • 21. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
    Bornhäuser M, Theuser C, Soucek S, Hölig K, Klingebiel T, Blau W, Fauser A, Runde V, Schwinger W, Rutt C, Ehninger G.
    Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931
    [Abstract] [Full Text] [Related]

  • 22. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
    Cao TM, Kusnierz-Glaz C, Valone F, Stockerl-Goldstein KE, Hu WW, Johnston L, Blume KG, Strober S, Negrin RS.
    Cancer; 2001 Jun 15; 91(12):2205-13. PubMed ID: 11413507
    [Abstract] [Full Text] [Related]

  • 23. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr 15; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 24. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
    Ogawa H, Ikegame K, Yoshihara S, Kawakami M, Fujioka T, Masuda T, Taniguchi Y, Hasei H, Kaida K, Inoue T, Kim EH, Kawase I.
    Biol Blood Marrow Transplant; 2006 Oct 15; 12(10):1073-84. PubMed ID: 17084371
    [Abstract] [Full Text] [Related]

  • 25. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype.
    Aversa F, Tabilio A, Velardi A, Cunningham I, Terenzi A, Falzetti F, Ruggeri L, Barbabietola G, Aristei C, Latini P, Reisner Y, Martelli MF.
    N Engl J Med; 1998 Oct 22; 339(17):1186-93. PubMed ID: 9780338
    [Abstract] [Full Text] [Related]

  • 26. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R, Enczmann J, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Wernet P, Göbel U, Laws HJ, Dilloo D.
    Klin Padiatr; 2005 Oct 22; 217(3):135-41. PubMed ID: 15858704
    [Abstract] [Full Text] [Related]

  • 27. Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Malignancies Working Party.
    Robin M, Ruggeri A, Labopin M, Niederwieser D, Tabrizi R, Sanz G, Bourhis JH, van Biezen A, Koenecke C, Blaise D, Tischer J, Craddock C, Maillard N, Mohty M, Russel N, Schetelig J, Finke J, Gluckman E, de Witte TM, Rocha V, Kroger N.
    Biol Blood Marrow Transplant; 2015 Mar 22; 21(3):489-95. PubMed ID: 25529382
    [Abstract] [Full Text] [Related]

  • 28. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ, Min WS, Cho BS, Eom KS, Kim YJ, Min CK, Lee S, Cho SG, Jin JY, Lee JW, Kim CC.
    Biol Blood Marrow Transplant; 2009 Jun 22; 15(6):704-17. PubMed ID: 19450755
    [Abstract] [Full Text] [Related]

  • 29. Single versus double unrelated umbilical cord blood units for allogeneic transplantation in adults with advanced haematological malignancies: a retrospective comparison of outcomes.
    Bradstock K, Hertzberg M, Kerridge I, Svennilson J, George B, McGurgan M, Huang G, Antonenas V, Gottlieb D.
    Intern Med J; 2009 Nov 22; 39(11):744-51. PubMed ID: 19220530
    [Abstract] [Full Text] [Related]

  • 30. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D.
    Biol Blood Marrow Transplant; 2009 Jan 22; 15(1):30-8. PubMed ID: 19135940
    [Abstract] [Full Text] [Related]

  • 31. Haematopoietic transplant potential of unrelated and related cord blood: the first six years of the EUROCORD/NETCORD Bank Germany.
    Kögler G, Somville T, Göbel U, Hakenberg P, Knipper A, Fischer J, Adams O, Krempe C, McKenzie C, Rüttgers H, Meier W, Bellmann O, Streng H, Ring A, Rosseck U, Rocha V, Wernet P.
    Klin Padiatr; 1999 Jan 22; 211(4):224-32. PubMed ID: 10472555
    [Abstract] [Full Text] [Related]

  • 32. A randomised study of allogeneic transplantation with stem cells from blood or bone marrow.
    Heldal D, Tjønnfjord G, Brinch L, Albrechtsen D, Egeland T, Steen R, Solheim BG, Evensen SA.
    Bone Marrow Transplant; 2000 Jun 22; 25(11):1129-36. PubMed ID: 10849524
    [Abstract] [Full Text] [Related]

  • 33. Reduced-intensity conditioning regimens before unrelated cord blood transplantation in adults with acute leukaemia and other haematological malignancies.
    Rocha V, Mohty M, Gluckman E, Rio B, Eurocord, Reduced-Intensity Conditioning Subcommittee of the Acute Leukaemia Working Party, French Society of Bone Marrow Transplantation and Cellular Therapy.
    Curr Opin Oncol; 2009 Jun 22; 21 Suppl 1():S31-4. PubMed ID: 19561411
    [Abstract] [Full Text] [Related]

  • 34. Allogeneic blood stem cell transplantation in advanced hematologic cancers.
    Przepiorka D, Anderlini P, Ippoliti C, Khouri I, Fietz T, Thall P, Mehra R, Giralt S, Gajewski J, Deisseroth AB, Cleary K, Champlin R, van Besien K, Andersson B, Körbling M.
    Bone Marrow Transplant; 1997 Mar 22; 19(5):455-60. PubMed ID: 9052911
    [Abstract] [Full Text] [Related]

  • 35. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May 22; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 36. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group.
    Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R, Ortega J, Souillet G, Ferreira E, Laporte JP, Fernandez M, Chastang C.
    N Engl J Med; 1997 Aug 07; 337(6):373-81. PubMed ID: 9241126
    [Abstract] [Full Text] [Related]

  • 37. Superior graft-versus-leukemia effect associated with transplantation of haploidentical compared with HLA-identical sibling donor grafts for high-risk acute leukemia: an historic comparison.
    Wang Y, Liu DH, Xu LP, Liu KY, Chen H, Chen YH, Han W, Shi HX, Huang XJ.
    Biol Blood Marrow Transplant; 2011 Jun 07; 17(6):821-30. PubMed ID: 20831895
    [Abstract] [Full Text] [Related]

  • 38. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
    Kröger N, Schetelig J, Zabelina T, Krüger W, Renges H, Stute N, Schrum J, Kabisch H, Siegert W, Zander AR.
    Bone Marrow Transplant; 2001 Oct 07; 28(7):643-7. PubMed ID: 11704786
    [Abstract] [Full Text] [Related]

  • 39. Generation of donor natural killer cells from CD34(+) progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation: a feasibility study.
    Yoon SR, Lee YS, Yang SH, Ahn KH, Lee JH, Lee JH, Kim DY, Kang YA, Jeon M, Seol M, Ryu SG, Chung JW, Choi I, Lee KH.
    Bone Marrow Transplant; 2010 Jun 07; 45(6):1038-46. PubMed ID: 19881555
    [Abstract] [Full Text] [Related]

  • 40. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
    Baron F, Lechanteur C, Willems E, Bruck F, Baudoux E, Seidel L, Vanbellinghen JF, Hafraoui K, Lejeune M, Gothot A, Fillet G, Beguin Y.
    Biol Blood Marrow Transplant; 2010 Jun 07; 16(6):838-47. PubMed ID: 20109568
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 48.